Company research
UNIVERSAL HEALTH SERVICES INC
CIK 352915Updated Sep 25, 2026
SecurityUHS · NYSE · equity
UHS price & chart
Loading TradingView…
NYSE:UHS on TradingView ↗About the company
Talkspace, a Universal Health Services, Inc. subsidiary, is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. Through its subsidiaries and affiliates, Talkspace offers a comprehensive suite of mental health services - including therapy for individuals, teens, and couples as well as psychiatry and medication management. Among its offerings is Tee, a standalone, clinician-informed AI mental health guide available to those 18+ for 24/7 behavioral support.
In the news
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND News provided by Universal Health Services, Inc. Nov 18, 2025, 16:20 ET Share this article Share to X Share this article Share to X KING OF PRUSSIA, Pa. , Nov. 18, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS ) announced today tha ↗
Recent filings
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
S-8 filing
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Other Events
Items 2.03, 8.01, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
FWP filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 15,527,593,000Source | 14,469,749,000Source | 13,967,602,000Source | 13,494,188,000Source |
| Property, Plant and Equipment, NetUSD | 7,008,097,000Source | 6,572,225,000Source | 6,124,529,000Source | 5,918,458,000Source |
| GoodwillUSD | 3,990,213,000Source | 3,932,879,000Source | 3,932,407,000Source | 3,909,456,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 137,797,000Source | 125,983,000Source | 119,439,000Source | 102,818,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,602,434,000Source | 2,177,751,000Source | 2,238,265,000Source | 2,017,722,000Source |
| Assets, CurrentUSD | 3,407,915,000Source | 2,816,288,000Source | 2,811,350,000Source | 2,537,340,000Source |
| Operating Lease, Right-of-Use AssetUSD | 374,239,000Source | 418,719,000Source | 433,962,000Source | 454,650,000Source |
| Other Assets, NoncurrentUSD | 5,111,581,000Source | 5,081,236,000Source | 5,031,723,000Source | 5,038,390,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Retained Earnings (Accumulated Deficit)USD | 7,992,755,000Source | 7,372,061,000Source | 6,798,930,000Source | 6,533,667,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 47,783,000Source | 7,201,000Source | 9,289,000Source | -9,668,000Source |
| Stockholders' Equity Attributable to ParentUSD | 7,275,792,000Source | 6,666,207,000Source | 6,149,001,000Source | 5,920,582,000Source |
| Liabilities and EquityUSD | 15,527,593,000Source | 14,469,749,000Source | 13,967,602,000Source | 13,494,188,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,239,601,000Source | 2,210,406,000Source | 2,013,347,000Source | 1,914,419,000Source |
| Operating Lease, Liability, CurrentUSD | 73,237,000Source | 74,649,000Source | 71,600,000Source | 67,776,000Source |
| Accounts Payable, CurrentUSD | 750,134,000Source | 632,001,000Source | 613,974,000Source | 636,601,000Source |
| Operating Lease, Liability, NoncurrentUSD | 340,715,000Source | 376,239,000Source | 382,559,000Source | 395,522,000Source |
| Deferred Income Tax Liabilities, NetUSD | 5,649,000Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 527,827,000Source | 655,806,000Source | 584,007,000Source | 487,669,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 62,996,000Source | 83,316,000Source | 47,714,000Source | 44,768,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 435,141,000Source | 383,991,000Source | 389,246,000Source | 394,335,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 748,158,000Source | 40,059,000Source | 126,686,000Source | 81,447,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 4,004,393,000Source | 4,464,482,000Source | 4,785,783,000Source | 4,726,533,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 71,000,000Source | 13,000,000Source | 5,000,000Source | 5,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 1,511,182,000Source | 1,163,109,000Source | 719,307,000Source | 656,982,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 95,688,000Source | 99,349,000Source | 87,720,000Source | 85,378,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 317,985,000Source | -67,355,000Source | 182,444,000Source | 258,338,000Source |
| Deferred Income Tax Expense (Benefit)USD | 50,741,000Source | -33,460,000Source | -17,958,000Source | -17,551,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 1,864,397,000Source | 2,067,101,000Source | 1,267,797,000Source | 996,023,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 47,804,000Source | 18,998,000Source | 3,728,000Source | 20,309,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,070,617,000Source | -911,109,000Source | -763,275,000Source | -647,296,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,015,152,000Source | 943,810,000Source | 743,055,000Source | 734,001,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 967,951,000Source | 670,754,000Source | 547,363,000Source | 832,918,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -749,727,000Source | -1,144,877,000Source | -493,945,000Source | -318,400,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 51,267,000Source | 53,346,000Source | 55,480,000Source | 58,449,000Source |
| Repayments of Long-term DebtUSD | 43,504,000Source | 2,640,001,000Source | 85,480,000Source | 89,367,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 46,570,000Source | 10,282,000Source | 13,633,000Source | 21,903,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 271,322,000Source | 224,752,000Source | 214,470,000Source | 200,837,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 156,041,000Source | 168,274,000Source | 200,446,000Source | 120,136,000Source |
| Income Taxes Paid, NetUSD | 470,865,000Source | 325,430,000Source | 257,896,000Source | 250,759,000Source |
| Additional Financial Items | ||||
| DepreciationUSD | 594,000,000Source | 559,600,000Source | 535,600,000Source | 544,000,000Source |
| Gain (Loss) on InvestmentsUSD | 93,291,000Source | — | — | — |
| GoodwillUSD | 3,990,213,000Source | 3,932,879,000Source | 3,932,407,000Source | 3,909,456,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | 0Source | — |
| Income Tax Expense (Benefit)USD | 460,959,000Source | 334,827,000Source | 221,119,000Source | 209,278,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,488,796,000Source | 1,142,097,000Source | 717,795,000Source | 675,609,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 22,386,000Source | 21,012,000Source | 1,512,000Source | -18,627,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 1,488,796,000Source | 1,142,047,000Source | 717,487,000Source | — |
| Operating ExpensesUSD | 15,370,814,000Source | 14,146,121,000Source | 13,106,595,000Source | 12,395,815,000Source |
| Operating Lease, ExpenseUSD | 148,234,000Source | 146,433,000Source | 141,026,000Source | 131,626,000Source |
| Other Nonoperating Income (Expense)USD | 134,194,000Source | 2,231,000Source | -28,281,000Source | -10,406,000Source |
| Payments of Financing CostsUSD | 382,000Source | 12,566,000Source | 308,000Source | 3,164,000Source |
| Proceeds from Issuance of Common StockUSD | 16,729,000Source | 15,070,000Source | 13,654,000Source | 14,068,000Source |
| Proceeds from (Payments to) Noncontrolling InterestsUSD | 22,846,000Source | 12,980,000Source | 2,762,000Source | -48,500,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | 93,000,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 17,364,829,000Source | 15,827,935,000Source | 14,281,976,000Source | 13,399,370,000Source |
| Operating Income (Loss)USD | 1,994,015,000Source | 1,681,814,000Source | 1,175,381,000Source | 1,003,555,000Source |
| Other Nonoperating Income (Expense)USD | 134,194,000Source | 2,231,000Source | -28,281,000Source | -10,406,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 1,972,141,000Source | 1,497,936,000Source | 940,426,000Source | 866,260,000Source |
| Income Tax Expense (Benefit)USD | 460,959,000Source | 334,827,000Source | 221,119,000Source | 209,278,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 22,386,000Source | 21,012,000Source | 1,512,000Source | -18,627,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,488,796,000Source | 1,142,097,000Source | 717,795,000Source | 675,609,000Source |
| Earnings Per Share, BasicUSD per share | 23.42Source | 17.16Source | 10.35Source | 9.23Source |
| Earnings Per Share, DilutedUSD per share | 23.1Source | 16.82Source | 10.23Source | 9.14Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 63,581,000Source | 66,554,000Source | 69,321,000Source | 73,118,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 64,462,000Source | 67,896,000Source | 70,125,000Source | 73,832,000Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 410,218,000Source | 368,287,000Source | 239,077,000Source | 226,829,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 618,743,000Source | 584,831,000Source | 568,041,000Source | 581,861,000Source |
| Gain (Loss) on InvestmentsUSD | 93,291,000Source | — | — | — |
| Interest ExpenseUSD | 156,068,000Source | 186,109,000Source | 206,674,000Source | 126,889,000Source |
| Labor and Related ExpenseUSD | 8,084,582,000Source | 7,518,687,000Source | 7,107,484,000Source | 6,762,256,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 1,488,796,000Source | 1,142,047,000Source | 717,487,000Source | — |
| Operating ExpensesUSD | 15,370,814,000Source | 14,146,121,000Source | 13,106,595,000Source | 12,395,815,000Source |
| Operating Lease, ExpenseUSD | 148,234,000Source | 146,433,000Source | 141,026,000Source | 131,626,000Source |
| Other Cost and Expense, OperatingUSD | 4,860,246,000Source | 4,308,384,000Source | 3,757,216,000Source | 3,445,733,000Source |
Filing attachments
d329184dex43.htm · 8-K · 2026-08-21
EX-4.3 2 d329184dex43.htm EX-4.3 EX-4.3 Exhibit 4.3 THIRD SUPPLEMENTAL INDENTURE Dated as of August 20, 2026 Among UNIVERSAL HEALTH SERVICES, INC. THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee and JPMORGAN CHASE BANK, N.A. as Collateral Agent 5.500% SENIOR SECURED NOTES DUE 2031 6.000% SENIOR SECURED NOTES DUE 2036 Supplemental to Indenture dated as of September 26, 2024 TABLE OF CONTENTS …
Read attachment ↗d329184dex46.htm · 8-K · 2026-08-21
EX-4.6 3 d329184dex46.htm EX-4.6 EX-4.6 Exhibit 4.6 ADDITIONAL AUTHORIZED REPRESENTATIVE JOINDER AGREEMENT, dated as of August 20, 2026 (this “Joinder Agreement”), among the Additional Authorized Representative (as defined below), Universal Health Services, Inc. (the “Borrower”), the other Grantors party hereto, and JPMorgan Chase Bank, N.A., as Collateral Agent (in such capacity, the “Collateral Agent”), as collateral agent for the Secured Parties and JPMorgan Chase Bank, N.A., as adminis…
Read attachment ↗uhs-ex99_1.htm · 8-K · 2026-08-17
EX-99.1 2 uhs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc. Creates nation's first full continuum of behavioral healthcare services, supporting people across every stage of their mental health journey KING OF PRUSSIA, PA and NEW YORK, NY (Aug. 17, 2026) - Universal Health Services, Inc. (NYSE: UHS) today announced the successful completion of its acquisition of Talkspace, Inc. (NASDAQ: TALK), bringing together one of the …
Read attachment ↗uhs-ex99_1.htm · 8-K · 2026-07-28
EX-99.1 2 uhs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE July 27, 2026 CONTACT: Darren Lehrich Vice President-Investor Relations 610-382-3310 Darren. Lehrich@uhsinc.com UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST Consolidated Results of Operations, As Reported and As Adjusted - Three-mo…
Read attachment ↗uhs-ex99_1.htm · 8-K · 2026-04-28
EX-99.1 2 uhs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE April 27, 2026 CONTACT: Darren Lehrich Vice President-Investor Relations 610-382-3310 Darren. Lehrich@uhsinc.com UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026 Consolidated Results of Operations, As Reported and As Adjusted - Three-month periods ended March 31, 2026 and 2025: KING OF PRUSSIA, P…
Read attachment ↗uhs-ex4_1.htm · 8-K · 2026-04-24
EX-4.1 2 uhs-ex4_1.htm EX-4.1 EX-4.1 Exhibit 4.1 FOURTH SUPPLEMENTAL INDENTURE This FOURTH SUPPLEMENTAL INDENTURE, dated as of April 22, 2026 (this “Supplemental Indenture”), among Universal Health Services, Inc., a Delaware corporation (the “Issuer”), each of the direct or indirect subsidiaries of the Issuer identified on Schedule 1 attached hereto as a guaranteeing subsidiary (each, a “Guaranteeing Subsidiary” and collectively, the “Guaranteeing Subsidiaries”), the other Guarantors (as …
Read attachment ↗